Abstract
Sickle cell disease causes pain that can manifest in chronic or acute crises. In addition to other possible complications, this pain can frequently place sickle cell patients in the emergency room and hospital. The high volume of patient visits requires an analysis of the quality of care for this group and a conscious effort to improve the care from providers. This study aims to evaluate the attitudes of United States hematologists toward current SCD management guidelines established by the American Society of Hematology (ASH). No statistically convincing evidence was found to support the hypothesis that not all United States hematologists agree with each ASH sickle cell treatment guideline. However, there is a deeper level of contextual understanding and discussion necessary to confidently make this conclusion.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
